Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Mao R, Liang J, Shen J, Ghosh S, Zhu L, Yang H
. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020; 5(5):425-427.
PMC: 7103943.
DOI: 10.1016/S2468-1253(20)30076-5.
View
2.
Taxonera C, Sagastagoitia I, Alba C, Manas N, Olivares D, Rey E
. 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020; 52(2):276-283.
PMC: 7267496.
DOI: 10.1111/apt.15804.
View
3.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso L, Rizzatti G
. Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre. United European Gastroenterol J. 2020; 8(7):775-781.
PMC: 7435006.
DOI: 10.1177/2050640620929133.
View
4.
Lopetuso L, Scaldaferri F, Ianiro G, Bibbo S, Settanni C, Papa A
. The impact of COVID-19 pandemic on IBD endoscopic procedures in a high-volume IBD Center. Endosc Int Open. 2020; 8(7):E980-E984.
PMC: 7311194.
DOI: 10.1055/a-1183-3073.
View
5.
Norsa L, Indriolo A, Sansotta N, Cosimo P, Greco S, DAntiga L
. Uneventful Course in Patients With Inflammatory Bowel Disease During the Severe Acute Respiratory Syndrome Coronavirus 2 Outbreak in Northern Italy. Gastroenterology. 2020; 159(1):371-372.
PMC: 7270273.
DOI: 10.1053/j.gastro.2020.03.062.
View